The Finnish Medicines Agency (Fimea) and the Finnish Safety and Chemicals Agency (Tukes) warn consumers and entrepreneurs about the safety risks associated with the Lemon Bottle product. The safety of the product has not been studied and the details of its composition are not reliable.
The laboratory of the Swiss medicine authority Swissmedic has examined the composition of the samples it has received and found that the composition of the injection fluid does not correspond to the composition declared by the manufacturer. The laboratory detected considerable differences in the composition of the product between the examined packages.
In Switzerland, Lemon Bottle has been classified as a medicinal product. The classification of the product is also under way in Finland. Lemon Bottle does not have a marketing authorisation for medicinal products in Finland.
The product is known to be used by companies in the beauty industry also in Finland. Lemon Bottle treatment is marketed for fat dissolving, meaning that it is used for the so-called lipolysis treatment.
Fimea and Tukes advise special caution with injectable beauty products marketed in the social media.
Lipolysis injections have also attracted wider attention recently and are associated with safety concerns, which are currently being investigated in more detail. Tukes reminds that products classified as cosmetics cannot be used in injection therapies.
For more information, please contact:
Fimea: Elina Cuthbert, Coordinator for Market Supervision, tel. +358 29 5223 487, Fimea’s email addresses are of the form [email protected]
Tukes: Annina Nyholm, Senior Officer, tel. +358 29 5052 069, [email protected], Finnish Safety and Chemicals Agency (Tukes)
